2010 - Review: Treatment for gestational diabetes reduces risk for shoulder dystocia
- Delivering a shoulder dystocia: how I do it. Chez, Ronald A.; Clark, Steven L. // Contemporary OB/GYN;Oct99, Vol. 44 Issue 10, p66
Describes the approach of Doctor Steven Clark, an expert on high risk pregnancy, in delivering a patient with shoulder dystocia. Definition of shoulder dystocia; Surgical procedures; Postdelivery examination.
- Comparison of Glyburide with Metformin in Treating Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis. Amin, Muhammad; Suksomboon, Naeti; Poolsup, Nalinee; Malik, Obaidullah // Clinical Drug Investigation;Jun2015, Vol. 35 Issue 6, p343
Background and Objective: Controversy has surrounded the treatment of gestational diabetes mellitus (GDM) for a long time. Although the use of both glyburide and metformin are recommended as an alternate to insulin if dietary therapy fails in GDM patients, it remains unclear whether both drugs...
- Cerebral Palsy and Cut Cords. J. D. // Midwifery Matters;Winter2004, Issue 103, p37
Presents cases of cerebral palsy during pregnancy. Delay of birth; Detection of dystocia; Implication of cutting the nuchal cord.
- The Use of Meta-Analysis in Cost-Effectiveness Analysis: Issues and Recommendations. Saint, S.; Veenstra, D.L.; Sullivan, S.D. // PharmacoEconomics;1999, Vol. 15 Issue 1, p1
Meta-analysis is used to statistically pool the results from individual studies, usually randomised trials, to obtain an estimate of the summary effect size across studies. The summary measure from a meta-analysis is often used to derive the probability of treatment success in a...
- Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? Kristian Thorlund; P J Devereaux; Jørn Wetterslev; Gordon Guyatt; John P A Ioannidis; Lehana Thabane; Lise-Lotte Gluud; Bodil Als-Nielsen; Christian Gluud // International Journal of Epidemiology;Feb2009, Vol. 38 Issue 1, p276
Background Results from apparently conclusive meta-analyses may be false. A limited number of events from a few small trials and the associated random error may be under-recognized sources of spurious findings. The information size (IS, i.e. number of participants) required for a reliable and...
- Blood Pressure Response to Transcendental Meditation: A Meta-analysis. Anderson, James W.; Chunxu Liu; Kryscio, Richard J. // American Journal of Hypertension;Mar2008, Vol. 21 Issue 3, p310
BACKGROUND Prior clinical trials suggest that the Transcendental Meditation technique may decrease blood pressure of normotensive and hypertensive individuals but study-quality issues have been raised. This study was designed to assess effects of Transcendental Meditation on blood pressure using...
- Why we need a broad perspective on meta-analysis. Gotzsche, Peter C // BMJ: British Medical Journal (International Edition);09/09/2000, Vol. 321 Issue 7261, p585
Editorial. Discusses factors affecting the usefulness of meta-analyses and clinical trials in medical research. Examples of the potential adverse health effects resulting from the narrow interpretation of meta-analysis results; Advantages of broad approaches to meta-analyses.
- Meta-Analysis of Multi-Arm Trials Using Empirical Logistic Transform. Chootrakool, Hathaikan; Jian Qing Shi // Open Medical Informatics Journal;2008, Vol. 2, p112
Meta-analysis of multi-arm trials has been used increasingly in recent years. The aim of meta-analysis for multi-arm trials is to combine evidence from all possible similar studies. In this paper we propose normal approximation models by using empirical logistic transform to compare different...
- Evolution of Heterogeneity (I2) Estimates and Their 95% Confidence Intervals in Large Meta-Analyses. Thorlund, Kristian; Imberger, Georgina; Johnston, Bradley C.; Walsh, Michael; Awad, Tahany; Thabane, Lehana; Gluud, Christian; Devereaux, P. J.; Wetterslev, Jørn // PLoS ONE;Jul2012, Vol. 7 Issue 7, p1
Background: Assessment of heterogeneity is essential in systematic reviews and meta-analyses of clinical trials. The most commonly used heterogeneity measure, I2, provides an estimate of the proportion of variability in a meta-analysis that is explained by differences between the included trials...